ArcticZymes Technologies ASA entered into an agreement with Biomatter (Biomatter Designs UAB) to develop new enzyme-based products. ArcticZymes Technologies (AZT) has entered a partnership agreement with Biomatter, a leading enzyme design company. Leveraging Biomatter's AI-driven Intelligent ArchitectureTM platform, the companies will co-develop new and improved products for AZT's enzyme portfolio.

The first focus project will be to explore the SAN portfolio in terms of new functions, properties and IP. The Intelligent ArchitectureTM platform combines generative AI and physical modelling to address the current limitations of enzyme engineering accuracy and time. The unique capabilities offered by the platform enables the design of enzymes with previously unattainable functions and properties.

By leveraging this technology and Biomatter's expertise, AZT will be able to expand its offering towards new and existing customers in both the molecular tools and biomanufacturing businesses.